After Sun Pharmaceutical Industries got a US Food and Drug Administration (FDA) warning regarding their plant in Halol, Gujarat, the company's shares fell by 7.4%. The pharmaceutical company's drug launches in the United States were affected due to FDA's probe of the Halol plant. We are working with an external consultant for remedial action, the company said.